Affordable Access

Publisher Website

Human leukocyte antigen class I alleles can predict response to pegylated interferon/ribavirin therapy in chronic hepatitis C Egyptian patients.

Authors
Type
Published Article
Journal
Archives of Iranian medicine
Publication Date
Volume
16
Issue
2
Pages
68–73
Identifiers
DOI: 013162/AIM.004
PMID: 23360626
Source
Medline

Abstract

HLA-A01 and HLA-B38 alleles are associated with and may have a role in the outcome of response to Peg-IFN plus ribavirin therapy in Egyptian patients diagnosed with chronic HCV infection. The use of immunologic markers to predict the outcome of treatment may help pharmacogenetic personalization of treatment for HCV infection.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F